number
emerg
reemerg
virus
caus
epidem
pandem
infecti
diseas
lead
major
devast
throughout
human
histori
therefor
develop
effect
safe
vaccin
virus
clearli
import
protect
atrisk
popul
previou
studi
shown
receptorbind
domain
rbd
spike
protein
sever
acut
respiratori
syndrom
sar
associ
coronaviru
sarscov
key
target
develop
sar
vaccin
review
highlight
key
advanc
develop
antivir
vaccin
target
rbd
spike
protein
emerg
reemerg
virus
use
sarscov
influenza
viru
hendra
viru
hev
nipah
viru
niv
exampl
figur
interact
receptorbind
domain
spike
emerg
viru
correspond
receptor
target
cell
epidem
pandem
emerg
reemerg
viral
infecti
diseas
sever
acut
respiratori
syndrom
sar
associ
coronaviru
sarscov
influenza
viru
hendra
viru
hev
nipah
viru
niv
pose
great
threat
public
health
human
safeti
econom
stabil
worldwid
therefor
develop
effect
safe
vaccin
prevent
diseas
urgent
need
safeti
concern
arisen
use
whole
inactiv
liveattenu
virus
develop
antivir
vaccin
therefor
scientist
attempt
design
vaccin
base
spike
protein
emerg
reemerg
virus
inde
spike
proteinbas
vaccin
safer
effect
vaccin
base
inactiv
liveattenu
virus
howev
new
concern
rais
use
fulllength
viral
spike
protein
develop
subunit
vaccin
nonneutr
immunodomin
epitop
spike
protein
may
induc
antibodi
enhanc
rather
neutral
viral
infect
otherwis
caus
harm
inflammatori
respons
vaccin
host
therefor
select
key
function
domain
contain
neutral
andor
tcell
epitop
immunogen
appear
import
strategi
develop
antivir
vaccin
infect
initi
upon
bind
viral
spike
protein
receptor
coreceptor
target
cell
surfac
mediat
spike
protein
receptorbind
domain
rbd
figur
therefor
rbd
play
import
role
viral
attach
fusion
entri
may
serv
attract
target
design
antivir
vaccin
previou
studi
demonstr
vaccin
base
rbd
spike
protein
sarscov
figur
induc
potent
neutral
antibodi
respons
protect
immun
vaccin
anim
suggest
rbd
spike
protein
virus
caus
emerg
reemerg
infecti
diseas
influenza
viru
figur
hev
niv
figur
may
also
serv
target
develop
vaccin
prevent
correspond
infecti
diseas
review
import
advanc
develop
antivir
vaccin
mainli
target
rbd
spike
protein
virus
caus
seriou
emerg
reemerg
infecti
diseas
past
three
decad
assess
feasibl
appli
similar
strategi
design
develop
vaccin
emerg
reemerg
virus
develop
sar
vaccin
target
rbd
sarscov
spike
protein
sar
first
new
infecti
diseas
identifi
twentyfirst
centuri
acut
sever
respiratori
diseas
origin
guangdong
provinc
china
sar
rapidli
spread
countri
area
around
world
sarscov
caus
agent
identifi
april
total
sar
case
death
report
outbreak
although
sarscov
believ
elimin
human
circul
juli
brief
recurr
laboratori
worker
china
late
earli
ubiqu
natur
pose
threat
reemerg
human
popul
zoonot
reintroduct
laboratori
escap
bioterror
thu
urgent
need
effect
strategi
devast
viral
agent
especi
highrisk
group
includ
elderli
healthcar
worker
laboratori
personnel
sarscov
primarili
transmit
via
droplet
respiratori
secret
close
persontoperson
contact
may
exist
respiratori
secret
stool
urin
sweat
sar
patient
enter
bodi
viru
bind
receptor
angiotensinconvert
enzym
express
primari
target
cell
pneumocyt
enterocyt
respiratori
system
suscept
cell
intestin
mucos
cell
renal
tubular
epitheli
cell
cerebr
neuron
immun
cell
permeat
cell
viru
replic
releas
infect
new
target
cell
figur
product
activ
level
proinflammatori
chemokin
cytokin
remark
elev
caus
signific
lung
tissu
damag
result
atyp
pneumonia
rapid
respiratori
deterior
failur
protein
rbd
sarscov
sarscov
envelop
viru
contain
singl
positivestrand
rna
genom
rna
encod
nonstructur
replicas
polyprotein
structur
protein
includ
spike
envelop
e
membran
nucleocapsid
n
protein
sarscov
residu
number
region
repres
posit
protein
sarscov
b
rbd
influenza
viru
ha
take
exampl
ha
consist
globular
head
subunit
contain
receptorbind
domain
rbd
membran
proxim
subunit
ahel
stalk
region
fp
lead
sequenc
sp
locat
nterminu
proteas
cleavag
site
subunit
character
specif
amino
acid
sequenc
eg
rerrrkkr
subunit
connect
interchain
disulfid
bond
infect
trigger
seri
humor
cellular
immun
respons
mainli
target
protein
protein
sarscov
type
transmembran
glycoprotein
n
terminu
surfac
infect
cell
viru
particl
precursor
consist
amino
acid
aa
cleav
proteas
surfac
subunit
aa
transmembran
unit
aa
figur
recogn
bind
host
cell
receptor
lead
conform
chang
mediat
viral
fusion
viral
envelop
host
cell
membran
minim
rbd
sarscov
protein
locat
subunit
aa
respons
viral
bind
host
cell
receptor
figur
besid
main
receptor
angiotensinconvert
enzym
sever
altern
receptor
dendrit
cellspecif
intercellular
adhes
nonintegrin
andor
liverlymph
nodespecif
intercellular
adhes
integrin
two
residu
aa
aa
rbd
determin
sar
progress
tropism
mutat
may
enhanc
animaltohuman
humantohuman
transmiss
residu
aa
protein
critic
dendrit
celllymph
nodespecif
intercellular
adhes
integrinmedi
viru
entri
vaccin
base
rbd
sarscov
protein
role
protein
receptor
bind
membran
fusion
make
perfect
target
vaccin
antivir
develop
sever
vaccin
candid
base
fulllength
protein
sarscov
shown
high
immunogen
induc
neutral
antibodi
respons
protect
sarscov
challeng
howev
vaccin
may
also
induc
harm
immun
respons
caus
liver
damag
vaccin
anim
andor
enhanc
sarscov
infect
antibodydepend
mechan
rais
signific
concern
safeti
ultim
protect
efficaci
vaccin
base
entir
protein
previou
studi
indic
rbd
protein
coronavirus
mous
hepat
viru
human
coronaviru
contain
major
antigen
determin
induc
neutral
antibodi
respons
therefor
postul
rbd
sarscov
may
also
target
neutral
antibodi
inde
found
major
neutral
antibodi
sera
sar
patient
anim
immun
inactiv
sarscov
strongli
react
rbd
sarscov
protein
sinc
deplet
rbdspecif
antibodi
result
elimin
neutral
activ
chen
et
al
also
demonstr
recombin
rbd
could
absorb
remov
neutral
antibodi
antisera
mice
rabbit
monkey
immun
liveattenu
modifi
vaccinia
ankara
viru
express
fulllength
protein
construct
sever
subunit
sar
vaccin
candid
use
recombin
rbd
express
escherichia
coli
insect
mammalian
cell
use
immun
mice
found
could
induc
highli
potent
broad
crossreact
neutral
antibodi
respons
protect
immun
challeng
live
sarscov
also
demonstr
intramuscular
mucos
immun
anim
adenoassoci
virusbas
figur
sarscov
life
cycl
host
cell
protein
structur
life
cycl
sarscov
sarscov
begin
life
cycl
protein
bind
cellular
receptor
receptor
bind
conform
chang
protein
facilit
viral
envelop
fusion
cell
membran
endosom
pathway
sarscov
releas
rna
host
cell
genom
rna
translat
viral
replicas
polyprotein
cleav
small
product
viral
proteinas
time
polymeras
produc
seri
subgenom
mrna
discontinu
transcript
final
translat
relev
viral
protein
viral
protein
genom
rna
subsequ
assembl
virion
er
golgi
bud
lumen
ergic
transport
via
vesicl
releas
cell
angiotensinconvert
enzym
er
endoplasm
reticulum
ergic
ergolgi
intermedi
compart
rbd
vaccin
could
elicit
strong
neutral
antibodi
respons
protect
sarscov
challeng
find
suggest
rbdbase
vaccin
consider
potenti
develop
safe
effect
sar
vaccin
prevent
futur
sar
epidem
therefor
previou
studi
sar
vaccin
proven
concept
rbdbase
vaccin
shown
strategi
could
also
appli
develop
vaccin
infecti
diseas
influenza
pandem
occur
frequent
human
popul
substanti
morbid
mortal
three
major
influenza
pandem
occur
last
centuri
respect
caus
differ
subtyp
influenza
viru
iav
includ
spanish
flu
asian
flu
hong
kong
flu
swineorigin
iav
soiv
origin
mexico
spread
global
caus
first
influenza
pandem
twentyfirst
centuri
sever
subtyp
iav
report
cross
speci
barrier
infect
human
exampl
march
avian
iav
seen
infect
two
person
hong
kong
result
mild
influenza
anoth
avian
iav
subtyp
report
infect
human
one
death
fowl
plagu
outbreak
netherland
furthermor
highli
pathogen
avian
influenza
viru
hpai
becom
continu
threat
public
health
worldwid
sinc
first
report
januari
case
report
world
health
organ
mortal
rate
approach
http
wwwwhointinfluenzahumananimalinterfaceengip
iav
belong
famili
orthomyxovirida
genom
viru
consist
eight
singlestrand
negativesens
rna
segment
encod
sever
import
protein
includ
surfac
protein
hemagglutinin
ha
neuraminidas
na
matrix
protein
nucleoprotein
np
matrix
protein
nonstructur
protein
well
polymeras
protein
pa
ha
na
two
import
envelop
glycoprotein
viru
iav
classifi
antigen
distinct
differ
na
accord
serotyp
ha
na
ha
iav
homotrim
play
import
role
viru
infect
singlechain
monom
initi
synthes
precursor
polypeptid
cleav
host
proteas
two
subunit
subunit
mainli
respons
receptor
bind
mediat
viral
attach
cellular
receptor
target
cell
known
sialic
acid
glycoprotein
glycolipid
differ
iav
recogn
differ
sialic
acid
receptor
exampl
human
bind
preferenti
sialic
acid
linkag
avian
equin
recogn
linkag
appear
swine
may
recogn
linkag
viral
attach
target
cell
subunit
locat
membraneproxim
helixrich
stem
region
mediat
viru
entri
target
cell
fusion
viral
envelop
cellular
membran
via
fusion
peptid
nterminu
ntermin
fusion
peptid
contain
highli
conserv
sequenc
among
iav
neutral
epitop
target
region
identifi
main
region
bind
cellular
receptor
rbd
locat
membranedist
end
ha
monom
span
less
aa
residu
around
residu
around
depend
differ
receptorbind
site
compos
three
structur
element
includ
well
sever
conserv
residu
posit
rbd
ha
primari
target
neutral
antibodi
base
antiiav
vaccin
design
develop
latest
influenza
pandem
caus
swineorigin
iav
coupl
continu
threat
highli
pathogen
avian
influenza
viru
make
essenti
develop
efficaci
vaccin
prevent
futur
influenza
pandem
epidem
convent
influenza
vaccin
prepar
basi
inactiv
viru
virus
grown
embryon
chicken
egg
inactiv
formalin
purifi
use
appropri
adjuv
howev
vaccin
mainli
administ
parenter
limit
abil
induc
high
immun
efficaci
prevent
heterolog
viru
infect
therefor
liveattenu
coldadapt
influenza
vaccin
produc
increas
immunogen
inject
intramuscularli
mice
live
influenza
virusbas
vaccin
induc
greater
protect
base
inactiv
viru
unfortun
safeti
concern
aros
possibl
recov
virul
potenti
reassort
virus
circul
influenza
virus
although
avail
influenza
vaccin
includ
base
dna
protein
viral
vector
well
viruslik
particl
may
induc
immun
respons
andor
protect
iav
infect
capac
elicit
highli
potent
broad
immun
respons
protect
greatli
restrict
disadvantag
made
essenti
explor
altern
novel
approach
futur
vaccin
develop
prefer
given
vaccin
capabl
stimul
broad
neutral
antibodi
respons
crossprotect
immun
diverg
iav
includ
pandem
strain
highli
pathogen
strain
discoveri
neutral
epitop
rbd
iav
neutral
antibodi
play
critic
role
protect
iav
infect
neutral
antibodi
could
induc
viru
infect
rais
vaccin
specif
antigen
produc
antibodi
may
neutral
variou
virus
first
recogn
target
specif
posit
epitop
viral
antigen
current
number
neutral
epitop
identifi
bind
neutral
antibodi
expos
loop
surround
receptor
bind
site
ha
protein
interf
viru
attach
select
antibodi
escap
mutant
use
genomefrag
phage
display
librari
group
us
food
drug
administr
abl
map
epitop
neutral
monoclon
antibodi
mab
two
aa
cluster
rbd
highli
conserv
sequenc
among
clade
virus
use
yeast
surfac
display
neutral
mab
fulllength
ha
research
identifi
conformationdepend
neutral
epitop
interfac
overlap
receptor
bind
site
anoth
conform
epitop
adjac
rbd
identifi
map
mab
ha
mab
show
receptorbind
domainsbas
antivir
vaccin
sb
jiang
et
al
crossreact
neutral
ha
inhibit
particular
strain
subtyp
iav
conform
neutral
epitop
cover
residu
apex
rbd
identifi
cocryst
structur
ha
mab
survivor
spanish
flu
epitop
conserv
pandem
virus
caus
spanish
flu
swineorigin
iav
studi
ha
qinghaityp
influenza
viru
reveal
antigen
epitop
globular
head
region
ha
contain
residu
neutral
epitop
residu
rbd
also
identifi
use
neutral
monoclon
ab
residu
wellconserv
across
differ
clade
strain
addit
neutral
epitop
identifi
antibodi
bind
assay
sever
immunodomin
epitop
identifi
select
escap
mutant
use
neutral
mab
neutral
epitop
cover
residu
posit
rbd
conserv
neutral
epitop
head
region
identifi
natur
occur
antibodi
neutral
epitop
residu
receptor
bind
site
ha
globular
region
identifi
two
human
neutral
antibodi
deriv
differ
donor
neutral
epitop
proven
highli
conserv
human
swineorigin
pandem
human
avian
strain
also
report
neutral
mab
capabl
recogn
receptorbind
pocket
iav
ha
indic
broad
neutral
iav
could
achiev
antibodi
target
rbd
pocket
prospect
develop
novel
influenza
vaccin
base
neutral
epitop
rbd
iav
identif
neutral
epitop
rbd
region
bring
hope
develop
innov
vaccin
identifi
epitop
region
may
appli
novel
vaccin
target
vaccin
base
neutral
epitop
could
induc
neutral
antibodi
broad
spectrum
iav
strain
studi
develop
vaccin
initi
shown
promis
result
report
e
coliexpress
recombin
protein
ha
rbd
contain
harbd
influenza
viru
immunogen
capac
trigger
neutral
antibodi
induc
protect
activ
test
ferret
model
studi
shown
recombin
vaccin
target
globular
head
rbd
region
fuse
flagellin
salmonella
typhimurium
fljb
gene
induc
protect
immun
infect
challeng
mice
demonstr
recombin
oligomer
protein
cover
avietnam
neutral
epitop
elicit
potent
neutral
antibodi
vaccin
mice
homolog
heterolog
strain
protect
ferret
homolog
heterolog
challeng
previou
studi
group
also
demonstr
protect
immun
vaccin
contain
region
challeng
pandem
influenza
viru
report
prabakaran
colleagu
indic
recombin
baculovirusexpress
trival
vaccin
cover
major
neutral
epitop
rbd
effect
neutral
virus
clade
protect
mice
challeng
three
differ
clade
clade
clade
clade
strain
recent
studi
also
reveal
recombin
vaccin
contain
rbd
neutral
region
induc
high
titer
antibodi
crossneutr
clade
strain
complet
protect
vaccin
mice
highdos
lethal
challeng
differ
strain
cover
clade
find
support
hypothesi
neutral
epitop
rbd
iav
ha
attract
target
develop
univers
influenza
vaccin
use
prevent
futur
influenza
pandem
epidem
caus
emerg
reemerg
iav
strain
hev
niv
emerg
zoonot
virus
discov
outbreak
australia
malaysia
respect
newli
defin
virus
hev
niv
belong
famili
paramyxovirida
genu
henipaviru
broad
speci
tropism
abil
caus
sever
diseas
human
anim
distinguish
hev
niv
zoonot
virus
symptom
hev
niv
infect
human
respiratori
includ
hemorrhag
edema
lung
encephalit
result
mening
princip
natur
reservoir
hev
niv
pteropid
fruit
bat
howev
recent
evid
henipaviru
infect
found
wider
rang
speci
includ
fli
fox
human
cat
hors
rabbit
laboratori
rodent
figur
hev
niv
potenti
caus
signific
morbid
mortal
human
consequ
major
econom
public
health
impact
classifi
biolog
safeti
pathogen
hev
niv
nonseg
negativestrand
rna
genosom
consist
transcript
unit
encod
six
major
structur
protein
includ
nucleocapsid
protein
n
phosphorprotein
p
matrix
protein
fusion
protein
f
glycoprotein
g
larg
protein
l
g
protein
contain
length
aa
respons
viru
bind
receptor
entri
host
cell
g
protein
neither
ha
neuraminidas
activ
play
import
role
hev
niv
bind
member
larg
famili
import
signal
protein
involv
cellcel
interact
bind
rbd
g
protein
receptor
facilit
f
proteinmedi
viral
fusion
target
cell
mutat
residu
rbd
g
protein
significantli
impair
viral
bind
fusion
activ
g
protein
hev
niv
compris
short
cytoplasm
tail
transmembran
domain
stalk
region
globular
head
domain
figur
globular
head
region
g
protein
contain
minim
rbd
aa
figur
g
protein
hev
niv
appear
domin
target
antigen
neutral
antibodi
vaccin
avail
prevent
henipaviru
diseas
human
sever
g
proteinbas
henipaviru
vaccin
candid
test
three
differ
anim
model
two
use
alvac
canarypox
vector
show
protect
niv
infect
pig
recombin
solubl
g
proteinbas
vaccin
adjuv
cpg
shown
induc
strong
immun
respons
ferret
niv
infect
model
could
protect
cat
niv
infect
first
human
neutral
mab
except
potenc
hev
niv
identifi
panel
alaninescan
mutant
g
protein
hev
test
bind
abil
human
neutral
antibodi
found
bind
hev
g
mutant
almost
complet
elimin
bind
activ
mutant
significantli
decreas
result
suggest
epitop
neutral
antibodi
overlap
rbd
hev
niv
g
protein
discontinu
residu
locat
rbd
critic
hev
niv
bind
receptor
base
find
design
rbdbase
henipaviru
vaccin
prevent
hev
niv
infect
feasibl
use
rbd
spike
protein
develop
antivir
vaccin
prevent
epidem
emerg
reemerg
viral
infecti
diseas
attract
research
interest
common
featur
rbd
spike
protein
sarscov
influenza
viru
hendra
viru
includ
locat
spike
protein
ii
mediat
bind
viru
target
cell
via
interact
viral
spike
protein
receptor
target
cell
iii
length
rang
aa
iv
contain
discontinu
neutral
epitop
rel
conserv
sequenc
rbd
play
critic
role
elucid
antivir
immun
respons
protect
immun
best
exampl
rbdbase
sar
vaccin
safe
vaccin
candid
shown
induc
effect
immun
respons
protect
immun
sarscov
thu
expect
rbdbase
sar
vaccin
one
first
sar
vaccin
go
clinic
trial
design
vaccin
abil
induc
highli
potent
crossreact
neutral
antibodi
high
bind
affin
recommend
follow
strategi
construct
immunogen
contain
discontinu
sequenc
bond
set
andor
induc
epitop
ii
induc
conform
chang
mutat
glycan
shield
nonneutr
immunodomin
epitop
immunogen
order
reduc
immunogen
epitop
iii
add
immunopotenti
motif
immunogen
order
enhanc
immunogen
rbdbase
vaccin
similar
rbd
sarscov
spike
protein
iav
ha
protein
rbd
span
aa
aa
three
conserv
structur
element
contain
primari
neutral
antibodi
epitop
serv
import
target
influenza
vaccin
develop
number
broadli
crossreact
neutral
mab
identifi
specif
bind
conformationdepend
neutral
epitop
interfac
overlap
adjac
rbd
recent
studi
shown
vaccin
mice
fusion
protein
consist
trimer
motif
foldon
human
immunoglobulin
g
fc
fragment
result
induct
potent
neutral
antibodi
respons
complet
crossclad
protect
infect
includ
elucid
neutral
mab
whose
epitop
map
rbd
unpublish
data
find
support
feasibl
develop
rbdbase
influenza
vaccin
anticip
rbdbase
influenza
vaccin
could
effect
diverg
iav
strain
includ
may
caus
futur
influenza
pandem
epidem
hev
niv
belong
famili
paramyxovirida
genu
henipaviru
emerg
zoonot
virus
caus
outbreak
human
australia
result
high
mortal
g
protein
hev
niv
contain
minim
rbd
overlap
aa
aa
globular
head
domain
first
human
neutral
antibodi
highli
potent
neutral
hev
niv
epitop
overlap
minim
rbd
g
protein
suggest
potenti
develop
rbdbase
henipaviru
vaccin
prevent
hev
niv
infect
besid
virus
mention
strategi
design
rbdbase
vaccin
also
appli
develop
vaccin
emerg
reemerg
virus
identifi
receptor
rbd
zair
ebolaviru
lake
victoria
marburgviru
although
receptor
virus
figur
structur
natur
reservoir
hev
princip
natur
reservoir
hev
fruit
bat
recent
evid
hendra
infect
indic
fli
fox
also
natur
reservoir
secondari
vector
laboratori
rodent
cat
dog
rabbit
deadend
host
hors
man
hev
six
major
structur
protein
nucleocapsid
protein
n
phosphorprotein
p
matrix
protein
fusion
protein
f
glycoprotein
g
larg
protein
l
hev
hendra
viru
receptorbind
domainsbas
antivir
vaccin
sb
jiang
et
al
clearli
defin
site
spike
protein
virus
bind
cellular
cofactor
facilit
viral
entri
may
also
use
design
vaccin
abl
induc
antibodi
block
viral
entri
neutral
viral
infect
exampl
entri
hepat
c
viru
hcv
hepatocyt
requir
least
four
cellular
cofactor
includ
tight
junction
protein
occludin
scaveng
receptor
bi
expect
site
protein
hcv
bind
cofactor
put
hcv
coreceptor
may
serv
target
develop
prevent
vaccin
hcv
near
futur
